Noelle Wright
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Noelle Wright has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Chengzhang Zhu
Department of Department of Physiology, Pharmacology & Therapeutics, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
1 shared publication - Chuan He
Department of Chemistry, University of Chicago, Chicago, USA
1 shared publication Juan C. Troncoso
Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
1 shared publicationJulie Asbury
Department of Physiology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
1 shared publicationLaura Gomez-Isaza
Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
1 shared publication- Shuying Sun
Department of Physiology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
1 shared publication
Latest Publications
- Open Access
DCPS modulates TDP-43 mediated neurodegeneration through P-body regulation
SUMMARY: The proteinopathy of the RNA-binding protein TDP-43, characterized by nuclear clearance and cytoplasmic inclusion, is a hallmark of multiple neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and Alzheimer’s disease (AD). Through CRISPR interference (CRISPRi) screening in human neurons, we identified the decapping enzyme scavenger (DCPS) as a novel genetic modifier of TDP-43 loss-of-function (LOF)-mediated neurotoxicity. Our findings reveal that TDP-43 LOF leads to aberrant mRNA degradation, via disrupting the properties and function of processing bodies (P-bodies). TDP-43 interacts with P-body component proteins, potentially influencing their dynamic equilibrium and assembly into ribonucleoprotein (RNP) granules. Reducing DCPS restores P-body integrity and RNA turnover, ultimately improving neuronal survival. Overall, this study highlights a novel role of TDP-43 in RNA processing through P-body regulation and identifies DCPS as a potential therapeutic target for TDP-43 proteinopathy-related neurodegenerative diseases.
Open AccessDCPS modulates TDP-43 mediated neurodegeneration through P-body regulation
SUMMARY: The proteinopathy of the RNA-binding protein TDP-43, characterized by nuclear clearance and cytoplasmic inclusion, is a hallmark of multiple neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and Alzheimer’s disease (AD). Through CRISPR interference (CRISPRi) screening in human neurons, we identified the decapping enzyme scavenger (DCPS) as a novel genetic modifier of TDP-43 loss-of-function (LOF)-mediated neurotoxicity. Our findings reveal that TDP-43 LOF leads to aberrant mRNA degradation, via disrupting the properties and function of processing bodies (P-bodies). TDP-43 interacts with P-body component proteins, potentially influencing their dynamic equilibrium and assembly into ribonucleoprotein (RNP) granules. Reducing DCPS restores P-body integrity and RNA turnover, ultimately improving neuronal survival. Overall, this study highlights a novel role of TDP-43 in RNA processing through P-body regulation and identifies DCPS as a potential therapeutic target for TDP-43 proteinopathy-related neurodegenerative diseases.